The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / August / Can Portal Hypertension Testing Go Non-invasive
Clinical care Microscopy and imaging Technology and innovation

Can Portal Hypertension Testing Go Non-invasive?

Combining routine laboratory findings with elastography and imaging may improve diagnostic triage

08/21/2026 News 3 min read
  • Full Article
  • Summary
  • Takeaways
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Topic Commentary

Share

Clinical Report: Can Portal Hypertension Testing Go Non-invasive?

Overview

Non-invasive tests combining liver and spleen stiffness measurements with laboratory findings may aid in identifying portal hypertension and determining the need for further testing.

Background

Portal hypertension is a significant complication of chronic liver disease, leading to serious conditions such as variceal bleeding and hepatic encephalopathy. Accurate assessment of portal hypertension is crucial for effective management and risk stratification. Traditional methods like hepatic venous pressure gradient measurement are invasive and not suitable for routine screening, necessitating the exploration of non-invasive alternatives.

Data Highlights

No numerical data available in the source material.

Key Findings

  • Transient elastography is a well-established method for measuring liver stiffness.
  • Baveno VII criteria utilize liver stiffness and platelet count to estimate the likelihood of clinically significant portal hypertension (CSPH).
  • A liver stiffness measurement of ≤15 kPa with a platelet count of ≥150 × 10^9/L can rule out CSPH.
  • Liver stiffness of ≥25 kPa can rule in CSPH.
  • Adding spleen stiffness measurement can reduce the indeterminate range of diagnoses from 40-60% to approximately 7-15%.
  • AI models combining imaging, laboratory, and clinical data show promise but require further validation.

Clinical Implications

Non-invasive testing methods could streamline the assessment of portal hypertension, making it more accessible for routine clinical practice. The integration of liver and spleen stiffness measurements with laboratory data may enhance diagnostic accuracy and reduce the need for invasive procedures.

Conclusion

The review suggests a stepwise approach to portal hypertension assessment, prioritizing non-invasive methods while retaining invasive measurements for definitive cases. Continued research is necessary to validate these non-invasive strategies in broader clinical settings.

Related Resources & Content

  1. Journal of Gastroenterology, Established Method for Assessing Hepatic Venous Pressure Gradient in Japan, 2024
  2. Intensive Care Medicine, Non-invasive intracranial pressure estimation in the intensive care unit: narrative review of methods and clinical applications, 2026
  3. Critical Care, AI-driven carotid artery compressibility assessment via point-of-care ultrasound for blood pressure estimation in critically ill and post-resuscitation patients: a prospective observational study, 2025
  4. ECRI Guidelines Trust®, AASLD practice guideline on noninvasive liver disease assessment of portal hypertension
  5. Cochrane, How accurate is liver and spleen stiffness measured by different elastography techniques in diagnosing clinically significant portal hypertension?
  6. Baveno VII, Renewing consensus in portal hypertension
  7. Glaucoma Physician — Home Tonometry Benefits and Limitations
  8. ECRI Guidelines Trust® - AASLD practice guideline on noninvasive liver disease assessment of portal hypertension.
  9. How accurate is liver and spleen stiffness measured by different elastography techniques in diagnosing clinically significant portal hypertension? | Cochrane
  10. Baveno VII – Renewing consensus in portal hypertension - PMC

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Intense Intestines
Microscopy and imaging
Intense Intestines

January 19, 2024

1 min read

Some powerful fluorescent microscopy in this Image of the Month…

Context Matters in Cancer Biology
Microscopy and imaging
Context Matters in Cancer Biology

December 27, 2021

1 min read

Akoya is leading the way with spatial phenotypic signatures – a novel class of biomarkers for predicting response to immunotherapy

When Pathology Goes 3D
Microscopy and imaging
When Pathology Goes 3D

February 2, 2022

1 min read

Stratifying cancers with non-destructive 3D pathology

Sacrificing Safety for Speed?
Microscopy and imaging
Sacrificing Safety for Speed?

February 4, 2022

3 min read

Wide adaptation of antigen testing could increase the risk of exposure to infectious SARS-CoV-2 samples

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.